• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Determination of acetylator phenotype in Caucasians with caffeine.

作者信息

Hildebrand M, Seifert W

机构信息

Research Laboratories, Schering AG, Berlin.

出版信息

Eur J Clin Pharmacol. 1989;37(5):525-6. doi: 10.1007/BF00558136.

DOI:10.1007/BF00558136
PMID:2598993
Abstract

Acetylator status in 595 healthy Caucasian volunteers was determined with caffeine. The test group consisted of 372 males and 223 females, 18 to 78 years of age. 312 volunteers were smokers. Caffeine was taken orally as Coffein Comprette (200 mg caffeine x H2O) and urine was collected for 8 h. The metabolic ratio (MR) of 5-acetylamino-6-formylamino-1-methyluracil (AFMU) to 1-methylxanthine (MX) was determined by HPLC. In total 61.7% of the group had a MR less than 0.48 and were classified as slow acetylators. MR varied from 0.01 to 0.47 in the slow acetylators and from 0.48 to 4.7 in the fast acetylator group. Clear dependence of acetylator type upon age, sex or smoking behaviour was not observed. The present study has confirmed the caffeine test as a feasible tool to determine acetylation capacity.

摘要

相似文献

1
Determination of acetylator phenotype in Caucasians with caffeine.
Eur J Clin Pharmacol. 1989;37(5):525-6. doi: 10.1007/BF00558136.
2
Acetylation phenotypes and biological variation in a French Caucasian population.法国白种人群体中的乙酰化表型与生物学变异
Eur J Clin Chem Clin Biochem. 1993 Feb;31(2):59-68. doi: 10.1515/cclm.1993.31.2.59.
3
Acetylator phenotyping: the urinary caffeine metabolite ratio in slow acetylators correlates with a marker of systemic NAT1 activity.乙酰化酶表型分析:慢乙酰化者尿液中咖啡因代谢物的比例与全身NAT1活性标志物相关。
Pharmacogenetics. 1994 Jun;4(3):166-70.
4
Lack of association between slow acetylator status and spontaneous lupus erythematosus.慢乙酰化状态与自发性红斑狼疮之间无关联。
Clin Pharmacol Ther. 1990 Aug;48(2):208-13. doi: 10.1038/clpt.1990.137.
5
Determination of N-acetylation phenotyping in a Greek population using caffeine as a metabolic probe.使用咖啡因作为代谢探针测定希腊人群中的N-乙酰化表型。
Eur J Drug Metab Pharmacokinet. 1998 Oct-Dec;23(4):501-6. doi: 10.1007/BF03190002.
6
A simplified and rapid test for acetylator phenotyping by use of the peak height ratio of two urinary caffeine metabolites.一种通过使用两种尿中咖啡因代谢物的峰高比来进行乙酰化酶表型分析的简化快速检测方法。
Clin Chem. 1989 May;35(5):848-51.
7
HPLC method for rapid determination of acetylator phenotype by measuring urinary caffeine metabolites.
J Pharm Biomed Anal. 1993 Oct;11(10):1017-21. doi: 10.1016/0731-7085(93)80063-7.
8
A population and family study of N-acetyltransferase using caffeine urinary metabolites.一项利用咖啡因尿液代谢物进行的N-乙酰转移酶的人群和家族研究。
Clin Pharmacol Ther. 1993 Aug;54(2):134-41. doi: 10.1038/clpt.1993.124.
9
Segregation analyses of four urinary caffeine metabolite ratios implicated in the determination of human acetylation phenotypes.对四种与人类乙酰化表型测定相关的尿咖啡因代谢物比率进行分离分析。
Genet Epidemiol. 1994;11(2):115-29. doi: 10.1002/gepi.1370110203.
10
Polymorphic N-acetylation of a caffeine metabolite.咖啡因代谢物的多态性N-乙酰化作用。
Clin Pharmacol Ther. 1983 Mar;33(3):355-9. doi: 10.1038/clpt.1983.45.

引用本文的文献

1
Clinical and Molecular Risk Factors of Anti-tubercular Therapy Induced Hepatitis.抗结核治疗所致肝炎的临床及分子危险因素
J Clin Exp Hepatol. 2019 Mar-Apr;9(2):200-206. doi: 10.1016/j.jceh.2018.06.012. Epub 2018 Jun 21.
2
Host factors in occupational diisocyanate asthma: a Swiss longitudinal study.职业性二异氰酸酯哮喘中的宿主因素:一项瑞士纵向研究。
Int Arch Occup Environ Health. 2005 Mar;78(2):158-63. doi: 10.1007/s00420-004-0568-4. Epub 2005 Feb 16.

本文引用的文献

1
Metabolism of isoniazid in man as related to the occurrence of peripheral neuritis.人体内异烟肼的代谢与周围神经炎发生的关系。
Am Rev Tuberc. 1954 Aug;70(2):266-73. doi: 10.1164/art.1954.70.2.266.
2
Determination of the acetylator phenotype and pharmacokinetics of some sulphonamides in man.人体中某些磺胺类药物乙酰化表型及药代动力学的测定
Clin Pharmacokinet. 1980 May-Jun;5(3):274-94. doi: 10.2165/00003088-198005030-00006.
3
Clinical pharmacokinetics of hydralazine.肼屈嗪的临床药代动力学。
Clin Pharmacokinet. 1982 May-Jun;7(3):185-205. doi: 10.2165/00003088-198207030-00001.
4
Polymorphic N-acetylation of a caffeine metabolite.咖啡因代谢物的多态性N-乙酰化作用。
Clin Pharmacol Ther. 1983 Mar;33(3):355-9. doi: 10.1038/clpt.1983.45.
5
A simple test for acetylator phenotype using caffeine.一种使用咖啡因检测乙酰化酶表型的简单测试。
Br J Clin Pharmacol. 1984 Apr;17(4):459-64. doi: 10.1111/j.1365-2125.1984.tb02372.x.
6
Variability in caffeine metabolism.咖啡因代谢的变异性。
Clin Pharmacol Ther. 1983 May;33(5):591-602. doi: 10.1038/clpt.1983.80.
7
Mass phenotyping of isoniazid inactivators by automated determination of acetylisoniazid in urine.通过自动测定尿液中的乙酰异烟肼对异烟肼灭活剂进行大规模表型分析。
Clin Chem. 1974 Jun;20(6):639-41.
8
An alternative test for acetylator phenotyping with caffeine.
Clin Pharmacol Ther. 1987 Nov;42(5):509-13. doi: 10.1038/clpt.1987.189.
9
N-acetylation pharmacogenetics.N-乙酰化药物遗传学
Pharmacol Rev. 1985 Mar;37(1):25-79.
10
Determination of dextromethorphan metabolizer phenotype in healthy volunteers.
Eur J Clin Pharmacol. 1989;36(3):315-8. doi: 10.1007/BF00558166.